Senescence-targeted engineered CAR-T immunotherapy: advances, challenges and perspectives for engineered senolytic immunotherapy
eBioMedicine
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Senescence-targeted engineered CAR-T immunotherapy: advances, challenges and perspectives for engineered senolytic immunotherapy. // eBioMedicine. – URL: https://www.sciencedirect.com/science/article/pii/S235239642600424X?dgcid=rss_sd_all
Senescence-targeted engineered CAR-T immunotherapy: advances, challenges and perspectives for engineered senolytic immunotherapy. eBioMedicine. https://www.sciencedirect.com/science/article/pii/S235239642600424X?dgcid=rss_sd_all
“Senescence-targeted engineered CAR-T immunotherapy: advances, challenges and perspectives for engineered senolytic immunotherapy.” eBioMedicine.
@article{article43582,
title = {Senescence-targeted engineered CAR-T immunotherapy: advances, challenges and perspectives for engineered senolytic immunotherapy},
journal = {eBioMedicine},
url = {https://www.sciencedirect.com/science/article/pii/S235239642600424X?dgcid=rss_sd_all}
}